ArticleCells2022

Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas.

Xin Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.